BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 15956049)

  • 1. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
    Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise.
    Park H; Kaushik VK; Constant S; Prentki M; Przybytkowski E; Ruderman NB; Saha AK
    J Biol Chem; 2002 Sep; 277(36):32571-7. PubMed ID: 12065578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
    Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
    Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
    Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
    Velasco G; Geelen MJ; Guzmán M
    Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
    Folmes CD; Lopaschuk GD
    Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
    Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
    Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
    Onay-Besikci A; Sambandam N
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-intensity contraction activates the alpha1-isoform of 5'-AMP-activated protein kinase in rat skeletal muscle.
    Toyoda T; Tanaka S; Ebihara K; Masuzaki H; Hosoda K; Sato K; Fushiki T; Nakao K; Hayashi T
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E583-90. PubMed ID: 16249251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
    Steinberg GR; Rush JW; Dyck DJ
    Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic 5'-AMP-activated protein kinase: zonal distribution and relationship to acetyl-CoA carboxylase activity in varying nutritional states.
    Witters LA; Gao G; Kemp BE; Quistorff B
    Arch Biochem Biophys; 1994 Feb; 308(2):413-9. PubMed ID: 7906505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
    Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
    Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
    Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
    J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise training decreases the concentration of malonyl-CoA and increases the expression and activity of malonyl-CoA decarboxylase in human muscle.
    Kuhl JE; Ruderman NB; Musi N; Goodyear LJ; Patti ME; Crunkhorn S; Dronamraju D; Thorell A; Nygren J; Ljungkvist O; Degerblad M; Stahle A; Brismar TB; Andersen KL; Saha AK; Efendic S; Bavenholm PN
    Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1296-303. PubMed ID: 16434556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
    Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
    Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
    Tomas E; Tsao TS; Saha AK; Murrey HE; Zhang Cc Cc; Itani SI; Lodish HF; Ruderman NB
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16309-13. PubMed ID: 12456889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
    Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart.
    Yatscoff MA; Jaswal JS; Grant MR; Greenwood R; Lukat T; Beker DL; Rebeyka IM; Lopaschuk GD
    Pediatr Res; 2008 Dec; 64(6):643-7. PubMed ID: 18614968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.